{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-007415","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.565064+00:00","generated_at":"2026-06-01T05:55:46.578062+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ENDRA Life Sciences prices $8M public offering of common stock and warrants","bullets":["Gross proceeds ~$8M; offering closed June 5, 2024 with Craig-Hallum as placement agent.","61.5M units sold at $0.13 each (or pre-funded at $0.1299), each with Series A and B warrants.","Series A and B warrants exercisable at $0.22; Series B includes alternate cashless exercise at $0.001 for 3 shares.","Warrants require stockholder approval and charter amendment; lock-up of 90 days for company/insiders.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-007415","json":"https://secwatch.observer/filing/0001654954-24-007415.json","markdown":"https://secwatch.observer/filing/0001654954-24-007415.md","text":"https://secwatch.observer/filing/0001654954-24-007415.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000165495424007415/0001654954-24-007415-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000165495424007415/ndra_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:55:46.578062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}